Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
AxonDx
AxonDx

AxonDx

Angel

AxonDx revolutionizes cancer diagnosis with nCYTE™ technology, offering fast, accurate, and cost-effective detection of Circulating Tumor Cells for personalized treatment.

HQ
Earlysville, VA, US
Founded
2013
Overview
Compare
Fundraising
Employees

Founded with a mission to revolutionize cancer diagnosis, AxonDx focuses on the early detection and characterization of Circulating Tumor Cells (CTCs) using their proprietary nCYTE™ technology. Their core vision is to provide fast, accurate, and cost-effective diagnostic solutions that enable personalized cancer treatment. AxonDx offers advanced research tools, including enhanced scanning optical systems powered by artificial intelligence and state-of-the-art biomarkers, to simplify the detection of rare cells in blood and other body fluids.

AxonDx has garnered attention from notable figures in the medical and biotech industries, attracting significant investment to advance their innovative diagnostic solutions. Among their key achievements is the successful implementation of nCYTE™ technology, which has shown promise in providing thorough prognostic insights into a patient's cancer. The impact of AxonDx's work is profound, offering a new avenue for early cancer detection and personalized treatment, potentially improving patient outcomes and transforming oncology diagnostics.

AxonDx - Similar Companies

NanoCytomics logo

NanoCytomics

nano-cytomics.com

CDx Diagnostics logo

CDx Diagnostics

OnCirc Diagnostics logo

OnCirc Diagnostics

AOA Dx logo

AOA Dx

aoadx.com

Aeena Dx logo

Aeena Dx

Circulogene Theranostics logo

Circulogene Theranostics

circulogene.com

Torpedo Diagnostics logo

Torpedo Diagnostics

Breath Diagnostics logo

Breath Diagnostics

Neodiagnostix logo

Neodiagnostix

neodiagnostix.com

LumaCyte logo

LumaCyte

lumacyte.com

Avant Diagnostics logo

Avant Diagnostics

Oncocyte logo

Oncocyte

oncocyte.com

LeukoDx logo

LeukoDx

BloodQ logo

BloodQ

bloodq.com

Epic Sciences logo

Epic Sciences

epicsciences.com

AxonDx - Quick Facts

Who are AxonDx's competitors?

Companies similar to AxonDx include NanoCytomics, CDx Diagnostics, OnCirc Diagnostics and AOA Dx.

When was AxonDx founded?

AxonDx was founded in 2013.

Where is AxonDx's headquarters located?

AxonDx's headquarters is located in Earlysville, VA, US.

When was AxonDx's last funding round?

AxonDx's most recent funding round was for $224.4k (USD) in May 2020.

How much has AxonDx raised to-date?

As of May 14, 2020, AxonDx has raised a total of $224.4k (USD).

How many employees does AxonDx have?

AxonDx has 6 employees as of Feb 4, 2024.

AxonDx - Classification

Industry
  • Hardware
Technology
  • AI
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Small Business
Main Product
  • Diagnostic Tests
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
ISIC
  • 2651Manufacture of measuring, testing, navigating and control equipment
Show 15 more industry codes
NAICS
  • 334500Navigational, Measuring, Electromedical, and Control Instruments Manufacturing
  • 334510Navigational, Measuring, Electromedical, and Control Instruments Manufacturing
  • 334516Analytical Laboratory Instrument Manufacturing
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 330000Manufacturing
  • 334000Computer and Electronic Product Manufacturing
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 3820Laboratory Apparatus And Analytical, Optical, Measuring, And Control
  • 3826Laboratory Analytical Instruments
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research